Results 91 to 100 of about 151,127 (351)

Association between PSA values and surveillance quality after prostate cancer surgery

Cancer Medicine, 2019
Background Although prostate‐specific antigen (PSA) testing is used for prostate cancer detection and posttreatment surveillance, thresholds in these settings differ.
Christina Hunter Chapman, Megan E. V. Caram, Archana Radhakrishnan, Alexander Tsodikov, Curtiland Deville, Jennifer Burns, Alexander Zaslavsky, Michael Chang, John T. Leppert, Timothy Hofer, Anne E. Sales, Sarah T. Hawley, Brent K. Hollenbeck, Ted A. Skolarus   +13 more
doaj   +1 more source

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy : a systematic review and economic evaluation [PDF]

, 2013
Peer reviewedPublisher ...
Boachie, C, Cruickshank, M, Ford, J A, Fraser, C, Kurban, L, Lam, T B, Mowatt, G, Padhani, A R, Royle, J, Scheenen, T W, Scotland, G, Tassie, E   +11 more
core   +3 more sources

Unveiling the potential of emerging microRNA panels as diagnostic biomarkers for prostate cancer: A review

UroPrecision, EarlyView.
Abstract Prostate cancer (PCa) is a multifaceted disease that envelops 1.41 million new cases globally. It is the second most common cancer reported in men. Its heterogeneity and indolent growth, coupled with incompetent early screening methods such as serum prostate‐specific antigen level estimations and digital rectal examinations, contribute to its ...
Anveshika Manoj, Gautam Prasad, Mohammad Kaleem Ahmad   +2 more
wiley   +1 more source

Preoperative MRI Parameters Predict Urinary Continence after Robot-Assisted Laparoscopic Prostatectomy in Prostatic Cancer Patients

Diagnostics, 2019
We aimed to investigate whether preoperative MRI findings could predict the bladder neck location on postoperative cystography and recovery of urinary incontinence after robot-assisted laparoscopic radical prostatectomy (RALP).
Shinji Fukui, Yoriaki Kagebayashi, Yusuke Iemura, Yoshiaki Matsumura, Shoji Samma   +4 more
doaj   +1 more source

Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells [PDF]

, 2012
DNA methylation might be the earliest somatic genome changes in prostate cancer that also play an important role in the process of tumor invasion, growth and metastasis.
D'Alessandro, Anna Maria, Di Clemente, Luigi, Di Pasquale, Boris, Dolo, Vincenza, Festuccia, Claudio, Gravina, Giovanni Luca, Mancini, Andrea, Marampon, Francesco, Muzi, Paola, Ranieri, Guido   +9 more
core   +1 more source

Development of a prognostic nomogram and genetic insights for prostate cancer patients with secondary primary malignancies: A SEER retrospective cohort study and Mendelian randomization analysis

UroPrecision, EarlyView.
Abstract Background Prostate cancer (PCa) patients are at risk of developing second primary malignancies (SPMs), which can significantly shorten their survival. Understanding the risk of SPMs and associated factors is crucial to the optimization of patient follow‐up.
Qi Zhang, Lufan Liang, Ziyu Liu, Ziyang Yang, Jiahao Cheng, Xuan Li, Yueting Huang, Weisi Chen, Jiazhen Yin, Ligong Chen, Zhang Cao, Di Gu   +11 more
wiley   +1 more source

Pathologic outcomes during the learning curve for robotic-assisted laparoscopic radical prostatectomy

International Brazilian Journal of Urology, 2008
OBJECTIVE: We report our initial experience with 62 patients undergoing robotic-assisted laparoscopic prostatectomy (RALP), focusing on the primary parameter of positive surgical margins.
Amul Shah, Onisuru T. Okotie, Lee Zhao, Michael R. Pins, Vishal Bhalani, Daniel P. Dalton   +5 more
doaj   +1 more source

Accuracy of multiparametric magnetic resonance imaging to detect significant prostate cancer and index lesion location [PDF]

, 2018
Background: Multiparametric magnetic resonance imaging (mpMRI) of the prostate appears to improve prostate cancer detection, but studies comparing mpMRI to histopathology at the time of radical prostatectomy (RP) are lacking.
Duncan, Ian, Goldman, Hariette, Harding, Catherine, McGirr, Joe, Seal, Alexa, Singh, Neha, Sowter, Steven   +6 more
core   +1 more source

Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: Can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism? [PDF]

, 2016
Background: Androgen deprivation therapy (ADT) is an effective palliation treatment in men with advanced prostate cancer (PC). However, ADT has well documented side effects that could alter the patient's health-related quality of life (HRQoL).
Benjamin, Benji, Ellett, Stephanie, Ferguson, Lynnette R., Goudie, Megan, Han, Dug Yeo, Holmes, Michael, Karunasinghe, Nishi, Keogh, Justin, Lange, Katja, Masters, Jonathan, Wang, Alice, Zhu, Shuotun, Zhu, Yifei   +12 more
core   +2 more sources

Epidemiology and organized testing for the diagnosis of prostate cancer in Sweden

UroPrecision, EarlyView.
Abstract Prostate cancer is the most diagnosed cancer and the leading cause of cancer‐related death among men in Sweden. The natural history and risk factors of prostate cancer, particularly within hereditary populations, have been extensively studied in the Swedish context. Despite the absence of national recommendations for prostate‐specific antigen (
Eugen Y. H. Wang
wiley   +1 more source